September/October 2005
Bernard Rupp
Macromolecular Crystallography and TB Structural Genomics Consortium
University of California, Lawrence Livermore National Laboratory
John J. Herbst, Ph. D. and Kenneth Dickinson, Ph.D.
Lead Discovery and Profiling
Bristol Myers-Squibb
Donna French, Ph.D. and Sue Masters, MEng, MBA
Amgen, Inc.
Adam Goldstein, Daivd Schieche, Jim Harter, Ravi Samavedam, Lindsay Wilkinson, Amy Manocchi
Amgen, Inc.
Dimitri Stamatiadis, Ph.D. MBA
Schering-Plough Research Institute
Irwin Silverstein
IBS Consulting in Quality
Michael L. Klein, Ph.D.
Formerly of Amgen, Inc.
Janet Hoogstraate, Ph.D.
AstraZeneca Research DMPK
Patrick J. Bell
Wyeth Pharmaceuticals
Tim Eaton
Sterile Manufacturing Specialist, AstraZeneca, UK
Weng Li Yoon
GlaxoSmithKline
aWilliam E. Pullman and bP.David Mozley
aTransForm Pharmaceuticals (formerly sanofi-aventis)
bMerck and Company
Douglas Stockdale
President, Stockdale Associates, Inc.
Dr. Catherine Tuleu
Department of Pharmaceutics & Centre for Paediatric Pharmacy Research
The School of Pharmacy, University of London, UK
Fred LaPlant and Xiaohua Zhang
Pfizer Global Research and Development